IQVIA Highlights Challenges in NHS Pathway Activation for Innovative Treatments
IQVIA, a global leader in healthcare intelligence, has emphasized the complexities involved in activating patient pathways within the NHS for innovative treatments. According to Arlene Neville, IQVIA's Transformation and Strategic Development lead in the UK, the gap between treatment approval and adoption often hinders the integration of new therapies into existing healthcare systems. The company stresses the importance of understanding and redesigning these pathways to ensure that treatments with proven clinical efficacy can be effectively implemented. Stephen Jowett, senior director at IQVIA, highlights the need for system readiness and activation to facilitate the delivery of new treatments, suggesting that organizations must focus on operational constraints and decision-making processes within the NHS. 
